Clinical trials: Dysgeusia
COVID-19
Smell in COVID-19 and Efficacy of Nasal Theophylline (SCENT 3)
The purpose of this Phase II trial is to test the effectiveness of intranasal theophylline irrigations for the treatment of COVID-19 related smell dysfunction.
- Trial name
- NCT05947643
- Testing
- theophylline
- Where
- United States
- Volunteers
- 77 people
- Sponsor
- Washington University School of Medicine
Dysgeusia
Gustin Gene Polymorphism and 6-n-propylthiouracil (PROP) Taste
The investigators evaluate the possible association of PROP taste with gustin gene polymorphism rs2274333 (A/G), salivary zinc ion concentration and BMI.
- Trial name
- gustinprop (NCT01097915)
- Where
- Italy
- Volunteers
- 170 people, healthy volunteers welcome
- Sponsor
- University of Cagliari
Non-Small Cell Lung Cancer, Dysgeusia
Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer
One of the most widely used treatments for non-small cell lung cancer (NSCLC) is the combination of paclitaxel-cisplatin. These drugs may contribute to taste alterations like dysgeusia.
- Conditions
- Non-Small Cell Lung Cancer, Dysgeusia, Taste Disorders, Lung Neoplasms
- Trial name
- NCT01540045
- Where
- Mexico
- Volunteers
- 40 people
- Sponsor
- Instituto Nacional de Cancerologia de Mexico